Provided by Tiger Fintech (Singapore) Pte. Ltd.

ACADIA Pharmaceuticals

15.38
-0.7400-4.59%
Post-market: 15.400.0200+0.13%17:43 EDT
Volume:2.16M
Turnover:33.35M
Market Cap:2.57B
PE:11.31
High:15.97
Open:15.93
Low:15.28
Close:16.12
Loading ...

RBC Capital Sticks to Its Buy Rating for ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
05 Apr

Why Is Acadia (ACAD) Down 11.1% Since Last Earnings Report?

Zacks
·
28 Mar

SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug

Zacks
·
27 Mar

Soleno jumps as analysts say US nod for rare disease drug transforms treatment options

Reuters
·
27 Mar

Is ACADIA Pharmaceuticals Inc. (ACAD) a Promising Biotech Stock According to Wall Street Analysts

Insider Monkey
·
26 Mar

Is ACADIA Pharmaceuticals Inc. (ACAD) the Best Nasdaq Stock Under $20 to Buy Now?

Insider Monkey
·
18 Mar

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
15 Mar

Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?

Zacks
·
14 Mar

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences

Business Wire
·
14 Mar

Acadia Pharmaceuticals assumed with an Equal Weight at Morgan Stanley

TIPRANKS
·
07 Mar

Balanced Outlook for ACADIA Pharmaceuticals Amid Uncertain Long-term Growth Prospects

TIPRANKS
·
07 Mar

ACADIA Pharmaceuticals Director Makes Significant Stock Sale

TIPRANKS
·
07 Mar

Clinical Data from Open-Label DAFFODIL™ Study Evaluating Long-term Safety of DAYBUE® (trofinetide) in Patients with Rett Syndrome Published in Med

Business Wire
·
05 Mar

Acadia Pharmaceuticals (ACAD) Q4 Earnings Lag Estimates (Revised)

Zacks
·
05 Mar

Acadia's Q4 Earnings Miss, Nuplazid & Daybue Drive Revenue Growth (Revised)

Zacks
·
04 Mar

ACADIA Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Simply Wall St.
·
04 Mar

ACADIA Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
04 Mar

Acadia Pharmaceuticals, Saniona announce results from ACP-711 cohorts

TIPRANKS
·
03 Mar

BRIEF-Saniona, Acadia Announce Initial Positive Results From ACP-711 Phase 1 Study

Reuters
·
03 Mar

Saniona Ab - Acp-711 Study Temporarily Paused Pending Regulatory Approval

THOMSON REUTERS
·
03 Mar